# Acetylcholinesterase Inhibitors: Vet Pharmacology Acetylcholinesterase inhibitors are a drug class that blocks the enzyme acetylcholinesterase (AChE), the enzyme responsible for breaking down acetylcholine at nerve synapses and neuromuscular junctions. When AChE is inhibited, acetylcholine accumulates and keeps stimulating cholinergic receptors. In [veterinary medicine](/blog/careers/veterinary-medicine-careers-from-clinical-practice-to-public-health), this mechanism is exploited in two opposite directions: as a therapeutic tool (for example, to stimulate gut motility or treat myasthenia gravis) and as a toxicological hazard (organophosphate and carbamate pesticides are among the most common causes of poisoning in dogs, cats, and livestock). This article covers the pharmacology, labeled uses, toxicity signs, and antidote protocols for acetylcholinesterase inhibitors relevant to veterinary practice. This article is educational and is not a substitute for veterinary diagnosis or treatment. ## At a Glance | Feature | Organophosphates | Carbamates | Reversible Agents (neostigmine, edrophonium) | |--|--|--|--| | Mechanism | Irreversible phosphorylation of AChE | Carbamylation (spontaneously reversible) | Reversible inhibition (competitive or non-covalent) | | Common veterinary examples | Diazinon, dichlorvos, chlorpyrifos, malathion, trichlorfon, pirimiphos-methyl | Methomyl, carbaryl, aldicarb | Neostigmine, edrophonium, pyridostigmine | | Primary veterinary uses | Ectoparasiticides, anthelmintics, agricultural pest control | Insecticides, molluscicides | Rumen motility stimulant, myasthenia gravis, reversal of neuromuscular blockade | | Route | Topical, oral, environmental | Oral, environmental | Injectable (IV, IM, SC) | | Onset | Minutes to hours (acute toxicity) | Minutes to hours | Minutes (IV), 15 to 30 min (IM) | | Duration | Prolonged (enzyme must be resynthesized) | Short to moderate (enzyme reactivates) | Short (edrophonium), moderate (neostigmine) | | Prescription status | Restricted use pesticide or prescription | Restricted use pesticide or prescription | Prescription only | | Antidote | Atropine (muscarinic) plus pralidoxime if early | Atropine (muscarinic) | Atropine for overdose | ## What Acetylcholinesterase Inhibitors Are Acetylcholinesterase is a serine hydrolase that terminates cholinergic neurotransmission by hydrolyzing acetylcholine into choline and acetate. The enzyme is present at all cholinergic synapses: parasympathetic postganglionic junctions, sympathetic cholinergic junctions (sweat glands), neuromuscular junctions, and within the central nervous system. An inhibitor of acetylcholinesterase prevents this hydrolysis, so acetylcholine accumulates in the synaptic cleft and produces sustained cholinergic stimulation. The clinical consequences of AChE inhibition depend on the dose, the specific agent, and the species. At therapeutic doses, reversible inhibitors produce controlled enhancement of cholinergic transmission. At toxic doses, irreversible inhibitors produce a cholinergic crisis that can be fatal within hours. Acetylcholinesterase inhibitors are classified by their mechanism of enzyme interaction: - **Reversible inhibitors** bind non-covalently or form a transient covalent bond. The enzyme recovers spontaneously when the drug is cleared. Neostigmine and edrophonium are examples. - **Carbamates** transfer a carbamyl group to the catalytic serine, forming a covalent but spontaneously hydrolyzable bond. Enzyme activity returns within hours to days as the carbamyl-enzyme complex dissociates. - **Organophosphates** phosphorylate the catalytic serine, forming a stable covalent bond. Spontaneous reactivation is extremely slow. The enzyme is effectively permanently inactivated unless an oxime reactivator (pralidoxime) is given before the bond "ages" into an irreversible state. The distinction between reversible, carbamylated, and phosphorylated enzyme states is the foundation of both therapeutic use and antidote strategy. ## How Acetylcholinesterase Inhibitors Work ### The Cholinergic Synapse At a cholinergic nerve terminal, an action potential triggers calcium influx and release of acetylcholine into the synaptic cleft. Acetylcholine diffuses across the cleft and binds to two receptor families: - **Muscarinic receptors** (M1 to M5) are G-protein coupled. They mediate parasympathetic effects: pupillary constriction (miosis), bradycardia, bronchoconstriction, increased glandular secretion, gastrointestinal smooth muscle contraction, and bladder detrusor contraction. - **Nicotinic receptors** are ligand-gated ion channels. They mediate fast excitatory transmission at the neuromuscular junction and at autonomic ganglia. Overstimulation causes muscle fasciculation, weakness, and eventually paralysis. Under normal conditions, acetylcholinesterase hydrolyzes acetylcholine within milliseconds, terminating the signal. When AChE is inhibited, acetylcholine remains in the cleft and repeatedly stimulates these receptors. ### Molecular Mechanism of Inhibition The active site of AChE contains a catalytic triad (serine, histidine, glutamate) at the bottom of a narrow aromatic gorge approximately 20 angstroms deep. Substrates must penetrate this gorge to reach the catalytic serine. The mechanism of inhibition depends on the inhibitor: - **Organophosphates** form a covalent bond with the catalytic serine via phosphorylation. The phosphorylated enzyme is stable. Over time, the phosphoryl group can undergo "aging," a dealkylation reaction that makes the bond essentially irreversible. Once aging occurs, oxime reactivators like pralidoxime cannot restore enzyme function. - **Carbamates** transfer a carbamyl group to the catalytic serine. This bond is covalent but hydrolyzes spontaneously, typically within 30 minutes to several hours. Because reactivation occurs without an oxime, carbamate poisoning generally has a shorter clinical course than organophosphate poisoning. - **Reversible inhibitors** like edrophonium bind via electrostatic and hydrogen-bonding interactions without forming a covalent bond. They compete with acetylcholine for the active site and dissociate rapidly. Neostigmine carbamylates the enzyme but at a slower rate and with faster spontaneous reactivation than organophosphate agents. A study of novel benzenesulfonamide derivatives in house flies (Musca domestica) demonstrated that the geometric positioning of an inhibitor within the aromatic gorge determines biological activity. Compounds that penetrated to within 2.5 to 2.8 angstroms of the catalytic serine produced complete adult kill, while compounds that stalled at 7.0 to 7.5 angstroms showed no mortality despite favorable binding energies [1]. This illustrates that AChE inhibition is not simply about binding affinity but about reaching the catalytic residue. ## Drug Class Table: Organophosphates, Carbamates, and Reversible Agents | Parameter | Organophosphates | Carbamates | Reversible Agents | |--|--|--|--| | **Enzyme interaction** | Irreversible phosphorylation | Carbamylation with spontaneous reactivation | Reversible binding or slow carbamylation | | **Enzyme recovery** | Days to weeks (new enzyme synthesis) | Hours to days (spontaneous hydrolysis) | Minutes to hours (drug clearance) | | **Veterinary examples** | Diazinon, dichlorvos, chlorpyrifos, malathion, trichlorfon, pirimiphos-methyl | Methomyl, carbaryl, aldicarb | Neostigmine, edrophonium, pyridostigmine | | **Veterinary uses** | Ectoparasiticides (topical dips, collars, pour-on), anthelmintics (older formulations), agricultural pest control | Insecticides for crops and animals, molluscicides | Rumen motility stimulation, myasthenia gravis diagnosis and treatment, reversal of competitive neuromuscular blockers | | **Toxicity signs** | SLUD (salivation, lacrimation, urination, diarrhea), miosis, bradycardia, bronchospasm, muscle fasciculation, weakness, respiratory paralysis, seizures | Same cholinergic crisis but shorter duration | Excessive salivation, bradycardia, muscle weakness (usually mild and self-limiting) | | **Antidote** | Atropine for muscarinic signs. Pralidoxime for nicotinic signs if given before aging | Atropine for muscarinic signs. Pralidoxime generally not required | Atropine if needed. Drug withdrawal | | **Species sensitivity** | All species susceptible. Sheep may develop delayed neuropathy weeks after exposure | All species susceptible. Dogs are commonly poisoned by methomyl bait | Rabbits and horses are sensitive to atropine | ## Veterinary Uses of Acetylcholinesterase Inhibitors ### Ectoparasiticides and Antiparasitic Agents Organophosphates have been used for decades as ectoparasiticides in veterinary medicine. Topical formulations, dips, and impregnated collars deliver the drug through the skin to kill fleas, ticks, and mites. The mechanism is straightforward: the parasite's AChE is inhibited, causing paralysis and death. Diazinon has been used as an agricultural and veterinary insecticide. A study in rats demonstrated that diazinon exposure at 20 mg/kg orally for 28 days produced pulmonary lipid peroxidation and suppressed antioxidant enzyme activity [2]. This illustrates the systemic toxicity risk when organophosphates are absorbed beyond the target parasite. Dichlorvos is another organophosphate used in veterinary and agricultural settings. In grass carp, a 96-hour LC50 of 4 microliters per liter was determined, with exposed fish showing hyperactivity, loss of balance, and erratic movements consistent with cholinergic overstimulation [3]. These behavioral signs mirror the early excitatory phase of organophosphate toxicity seen in mammals. Malathion remains in use as an adulticide for mosquito control. Its toxicity to Culex quinquefasciatus mosquitoes is temperature-dependent, with higher mortality at warmer temperatures [4]. This environmental modulation of toxicity is relevant to field applications. Carbamate insecticides such as methomyl are widely available and highly toxic to companion animals. A case series of five dogs with confirmed methomyl poisoning found pulmonary edema and multisystemic congestion and hemorrhage, with the most severe lesions in the respiratory tract [5]. Methomyl acts as an acetylcholinesterase inhibitor, and its ready availability makes it a common cause of accidental and intentional poisoning in dogs. ### Rumen Motility Stimulation Neostigmine, a reversible carbamate, is used in veterinary medicine to stimulate gastrointestinal and rumen motility. By enhancing cholinergic transmission at smooth muscle junctions, it increases contractions of the forestomach and intestine. This is useful in cases of rumen atony or ileus where motility has stalled. The effect is dose-dependent and reversible, making it safer than irreversible inhibitors for this indication. ### Myasthenia Gravis Myasthenia gravis is an autoimmune disease in which antibodies destroy or block nicotinic acetylcholine receptors at the neuromuscular junction. The result is muscle weakness that worsens with activity. Reversible acetylcholinesterase inhibitors such as pyridostigmine and neostigmine prolong the action of acetylcholine at the remaining receptors, improving muscle strength. Edrophonium is used as a diagnostic test: a short-acting inhibitor is administered intravenously, and a rapid transient improvement in muscle strength supports the diagnosis. ### Reversal of Neuromuscular Blockade Neostigmine is used to reverse non-depolarizing neuromuscular blocking agents after surgery. By increasing acetylcholine at the neuromuscular junction, it competes with the blocker and restores transmission. Atropine is typically co-administered to prevent bradycardia from the muscarinic effects of neostigmine. ### Contrast with Human Alzheimer Drugs Donepezil, galantamine, and rivastigmine are reversible AChE inhibitors used in human medicine to slow cognitive decline in Alzheimer's disease. These agents are not used in veterinary medicine for cognitive dysfunction. They appear in the literature primarily as reference compounds in drug discovery studies. For example, galantamine showed the strongest AChE inhibition (4.23 micrograms per milliliter) among compounds tested in an in vitro study of Algerian medicinal plant extracts [6]. This human drug context is mentioned only to distinguish it from veterinary applications. ## Toxicity: Cholinergic Crisis ### Clinical Signs Acetylcholinesterase inhibitor toxicity produces a cholinergic crisis. The signs can be organized by receptor type: **Muscarinic signs (parasympathetic overstimulation):** - Salivation (SLUD: salivation, lacrimation, urination, diarrhea) - Miosis (pinpoint pupils) - Bradycardia - Bronchoconstriction and increased bronchial secretions - Vomiting and diarrhea - Urinary incontinence **Nicotinic signs (neuromuscular junction and ganglia):** - Muscle fasciculation - Muscle weakness and tremors - Respiratory muscle paralysis - Tachycardia (from ganglionic stimulation) **Central nervous system signs:** - Anxiety and restlessness - Seizures - Respiratory depression - Coma A retrospective study of 39 cats with acute organophosphate or carbamate intoxication found a mortality rate of 15%. Low respiratory rate and low rectal temperature at presentation were associated with death. Common clinical signs included weakness, ataxia, apathy, recumbency, anorexia, and bradycardia. Decreased serum butyrylcholinesterase activity, acidemia, hypercarbemia, and total hypocalcemia were common biochemical abnormalities [7]. This study provides species-specific data on the clinical course of cholinergic toxicity in cats. ### Organophosphate-Induced Delayed Neuropathy A distinct syndrome called organophosphate-induced delayed neuropathy (OPIDN) can occur days to weeks after acute exposure. It is not caused by AChE inhibition but by inhibition of neuropathy target esterase (NTE), a different enzyme. The result is distal axonopathy with progressive weakness and ataxia. Two suspected outbreaks of OPIDN were described in Australian Merino sheep in Uruguay. The outbreaks occurred 21 and 44 days after a single cutaneous exposure to pirimiphos-methyl and diazinon, respectively. Affected sheep had massive skin perforations from lobed needlegrass (Nassella charruana), which likely enhanced dermal absorption of the organophosphate. Histologic examination revealed axonal spheroids, vacuolation, and digestion chambers in the spinal cord, predominantly involving the ventral horn and propriospinal tracts [8]. This case demonstrates that dermal absorption through damaged skin can produce delayed neurotoxicity in livestock. Drosophila melanogaster has been used as a model to study OPIDN through mutations in the swiss cheese gene, the fly ortholog of human PNPLA6/NTE. This allows investigation of delayed neuropathy independent of cholinergic effects [9]. ### Diagnosis Diagnosis of acetylcholinesterase inhibitor toxicity relies on a combination of history, clinical signs, and laboratory confirmation. Plasma or whole blood cholinesterase activity is the most useful biomarker. A study of Griffon vultures established reference ranges for plasma cholinesterase activity, confirming that the dominant form in plasma is acetylcholinesterase. Healthy Griffon vultures had cholinesterase levels of 0.601 plus or minus 0.011 units per milliliter [10]. Species-specific reference ranges are essential because basal cholinesterase activity varies widely between species. In dogs with suspected methomyl poisoning, diagnosis was confirmed by detecting methomyl in gastric contents using gas chromatography-mass spectrometry [5]. This approach is useful when the specific agent is unknown. ## Antidote Protocols ### Atropine for Muscarinic Signs Atropine is a competitive muscarinic receptor antagonist. It blocks the effects of excess acetylcholine at muscarinic receptors, reversing salivation, lacrimation, bradycardia, bronchoconstriction, and gastrointestinal hyperactivity. Atropine does not reverse nicotinic signs such as muscle fasciculation or respiratory paralysis. Atropine should be given to effect, meaning the dose is titrated until muscarinic signs (especially bradycardia and excessive secretions) are controlled. In the cat case series, atropine sulfate was administered to 54% of cats, and pralidoxime was given to 74% [7]. The high rate of pralidoxime use in that study reflects the severity of cases presenting to a teaching hospital. ### Pralidoxime for Organophosphate Nicotinic Signs Pralidoxime (2-PAM) is an oxime reactivator. It works by nucleophilic attack on the phosphorus atom of the phosphorylated enzyme, removing the phosphoryl group and restoring AChE activity. Pralidoxime is effective only for organophosphate poisoning, not carbamate poisoning. It must be given before the phosphorylated enzyme undergoes aging, the dealkylation process that makes the bond irreversible. Once aging occurs, pralidoxime cannot reactivate the enzyme. Pralidoxime is most effective when given early, ideally within hours of exposure. It addresses nicotinic signs (muscle weakness, fasciculation, respiratory paralysis) that atropine cannot reverse. In the cat study, pralidoxime was given to 74% of cats, often in combination with atropine [7]. ### Adjunctive Treatments Diphenhydramine, an H1-antihistamine, has been studied as an adjunctive antidote for cholinesterase inhibitor poisoning. A meta-analysis of median lethal doses in experimental animals found that diphenhydramine significantly increased the LD50 of cholinesterase inhibitors (organophosphates, carbamates, and imidocarb) compared to controls. The combined effect size was -3.71 (standard error 0.36, 95% CI -4.46 to -2.97) [11]. The mechanism may involve antagonism of histamine release or direct effects on cholinergic transmission. In the cat case series, diphenhydramine was administered to 59% of cats [7]. Supportive care includes oxygen supplementation, seizure control with benzodiazepines, and fluid therapy. Respiratory paralysis may require mechanical ventilation. ### Species Differences in Atropine Sensitivity Atropine sensitivity varies significantly across species. Rabbits have high levels of atropine esterase in their serum, an enzyme that rapidly metabolizes atropine. This means rabbits require higher doses of atropine than other species to achieve the same therapeutic effect. Conversely, horses are relatively sensitive to atropine and may develop colic or ileus from even therapeutic doses, because atropine reduces gastrointestinal motility. These species differences are clinically important when treating cholinergic toxicity. A rabbit with organophosphate poisoning may need more atropine than a dog of similar size, while a horse may develop adverse gastrointestinal effects from standard atropine doses. ## What Acetylcholinesterase Inhibitors Do Not Cover Acetylcholinesterase inhibitors are not antibiotics, anti-inflammatory drugs, or analgesics. They do not treat infections, pain, or inflammation directly. Their therapeutic use is limited to conditions where enhanced cholinergic transmission is beneficial: rumen atony, myasthenia gravis, and reversal of neuromuscular blockade. Organophosphate and carbamate pesticides are not selective for parasite AChE over host AChE. This lack of selectivity is the basis for their toxicity. A topical organophosphate applied to a dog's skin can be absorbed systemically and inhibit the dog's own AChE if the dose is excessive or the skin barrier is compromised. Reversible inhibitors like neostigmine do not cross the blood-brain barrier significantly, so they have limited central nervous system effects. Organophosphates, being more lipid-soluble, do cross into the brain and can cause seizures and central nervous system depression. ## How to Give These Medications Organophosphate and carbamate pesticides are typically applied topically as dips, sprays, or pour-on formulations. Label instructions must be followed exactly. Over-application, application to damaged skin, or use on a species not listed on the label can cause systemic toxicity. Neostigmine and edrophonium are given by injection. Neostigmine can be administered intravenously, intramuscularly, or subcutaneously. Edrophonium is given intravenously for diagnostic testing. Doses are determined by the veterinarian based on the indication and the patient's response. Pyridostigmine is available as an oral tablet for long-term management of myasthenia gravis. The dose is titrated to the individual patient's needs. ## Side Effects and What to Do About Them Therapeutic use of reversible acetylcholinesterase inhibitors can cause: - Excessive salivation - Bradycardia - Abdominal cramping and diarrhea - Muscle weakness (if the dose is too high) These effects are usually mild and resolve when the dose is reduced or the drug is discontinued. Atropine can be given to counteract muscarinic side effects if they are severe. Toxicity from organophosphate or carbamate exposure produces the cholinergic crisis described above. If you suspect your pet has been exposed to an organophosphate or carbamate pesticide, contact a veterinarian or animal poison control immediately. Do not induce vomiting unless instructed to do so. ## Which Animals Should Not Receive These Medications Acetylcholinesterase inhibitors should be used with caution in animals with: - **Bradycardia or heart block:** Cholinergic stimulation can worsen bradycardia. - **Asthma or bronchospastic disease:** Bronchoconstriction can be exacerbated. - **Peptic ulcer disease:** Increased gastric acid secretion can worsen ulcers. - **Intestinal obstruction:** Stimulating motility against a mechanical obstruction can cause perforation. - **Urinary obstruction:** Increased detrusor contraction against an obstruction can cause bladder rupture. Organophosphate and carbamate pesticides should never be applied to animals with damaged skin, as absorption is enhanced. The sheep OPIDN outbreaks in Uruguay occurred when skin perforations from needlegrass allowed excessive dermal absorption of organophosphate [8]. Rabbits should not receive atropine without careful dose adjustment because of their high atropine esterase activity. Horses should receive atropine only when the benefits outweigh the risk of colic. ## Interactions Acetylcholinesterase inhibitors interact with other drugs that affect cholinergic transmission: - **Anticholinergic drugs** (atropine, glycopyrrolate) antagonize the muscarinic effects of AChE inhibitors. - **Neuromuscular blocking agents** (succinylcholine, non-depolarizing blockers) may have prolonged or altered effects when combined with AChE inhibitors. - **Corticosteroids** may increase the risk of organophosphate-induced delayed neuropathy. - **Other cholinesterase inhibitors** (including certain insecticides and chemical warfare agents) have additive effects. Organophosphate exposure can also affect drug metabolism. A study in goats with subclinical fatty liver found that intermittent trichlorfon poisoning followed by antidote rescue produced hepatic injury with immune activation and energy metabolism reprogramming. Proteomics revealed 326 altered proteins, including complement proteins C3 and C5 and TNF pathway molecules [12]. This suggests that organophosphate exposure can alter hepatic function and potentially affect drug metabolism. ## How Acetylcholinesterase Inhibitors Compare with Alternatives For ectoparasite control, modern alternatives to organophosphates include: - **Pyrethroids** (deltamethrin, permethrin): Act on voltage-gated sodium channels. A study comparing deltamethrin and malathion toxicity in mosquitoes found that deltamethrin toxicity increased at lower relative humidities, while malathion toxicity was temperature-dependent [4]. - **Isoxazolines** (fluralaner, afoxolaner): Act on GABA-gated chloride channels. Highly selective for invertebrate receptors. - **Insect growth regulators** (methoprene, pyriproxyfen): Disrupt insect development. These alternatives generally have a wider safety margin than organophosphates because they target receptors or enzymes not present in mammals or with lower affinity for mammalian targets. For rumen motility, alternatives to neostigmine include metoclopramide (a dopamine antagonist with prokinetic effects) and erythromycin (a motilin receptor agonist). These agents have different mechanisms and side effect profiles. For myasthenia gravis, immunosuppressive therapy (corticosteroids, azathioprine, mycophenolate) addresses the underlying autoimmune process, while AChE inhibitors provide symptomatic relief. ## Questions to Ask a Veterinarian 1. Is this medication appropriate for my pet's species and condition? 2. What side effects should I watch for at home? 3. What should I do if I miss a dose? 4. Are there any drug interactions with my pet's other medications? 5. How long will my pet need this medication? 6. What monitoring tests are needed while my pet is on this drug? 7. What is the antidote if my pet accidentally gets too much? 8. Should I keep this medication away from children and other pets? ## Clinical Relevance, Limitations and Common Mistakes Acetylcholinesterase inhibitors remain clinically relevant in veterinary medicine for both therapeutic and toxicological reasons. Organophosphate and carbamate pesticides continue to cause poisoning in companion animals and livestock. The cat case series found a 15% mortality rate, with low respiratory rate and low rectal temperature at presentation associated with death [7]. Early recognition and treatment are critical. The most common mistakes in managing AChE inhibitor toxicity include: 1. **Giving atropine alone for organophosphate poisoning.** Atropine reverses muscarinic signs but not nicotinic signs. Pralidoxime is needed for the nicotinic component if given early. 2. **Giving pralidoxime for carbamate poisoning.** Carbamates spontaneously reactivate, so pralidoxime is not needed and may theoretically worsen toxicity by prolonging carbamate effects. 3. **Delaying pralidoxime administration.** Once the phosphorylated enzyme ages, pralidoxime is ineffective. Early administration is essential. 4. **Ignoring species differences in atropine sensitivity.** Rabbits need higher doses, and horses are prone to colic from atropine. 5. **Applying organophosphate pesticides to damaged skin.** The sheep OPIDN outbreaks in Uruguay illustrate that skin lesions can dramatically increase absorption and lead to delayed neurotoxicity [8]. 6. **Failing to establish species-specific cholinesterase reference ranges.** Basal cholinesterase activity varies widely, and without reference values, interpretation of decreased activity is difficult [10]. Individual cases require veterinary assessment. This article provides general pharmacology and toxicology information, not a treatment protocol for a specific patient. ## Frequently Asked Questions ### What are acetylcholinesterase inhibitors used for in veterinary medicine? They are used as ectoparasiticides (organophosphates and carbamates), rumen motility stimulants (neostigmine), and treatments for myasthenia gravis (pyridostigmine, edrophonium). ### What does SLUD stand for in cholinergic toxicity? SLUD stands for salivation, lacrimation, urination, and diarrhea. These are the classic muscarinic signs of acetylcholinesterase inhibitor poisoning. ### What is the antidote for organophosphate poisoning in animals? Atropine is given for muscarinic signs, and pralidoxime is given for nicotinic signs if administered before the enzyme ages. ### Why is pralidoxime not used for carbamate poisoning? Carbamates spontaneously dissociate from the enzyme, so reactivation occurs without an oxime. Pralidoxime is not needed and may be harmful. ### Are rabbits more sensitive to atropine than other animals? Rabbits have high levels of atropine esterase, an enzyme that breaks down atropine rapidly. They require higher doses to achieve the same effect. ### Can organophosphate poisoning cause delayed symptoms in sheep? Yes. Organophosphate-induced delayed neuropathy can occur days to weeks after exposure, causing progressive weakness and ataxia from spinal cord axonopathy. ### How is acetylcholinesterase inhibitor toxicity diagnosed? Diagnosis relies on history, clinical signs, and measurement of plasma or blood cholinesterase activity. Species-specific reference ranges are needed for interpretation. ### What should I do if my pet is exposed to an organophosphate or carbamate pesticide? Contact a veterinarian or animal poison control immediately. Do not induce vomiting unless instructed. Bring the pesticide container or label if possible. ```mermaid flowchart TD A[Exposure suspected] --> B{Cholinergic signs present} B -->|Yes| C[Give atropine for muscarinic signs] B -->|No| D[Monitor and decontaminate] C --> E{Organophosphate or carbamate} E -->|Organophosphate| F[Give pralidoxime early] E -->|Carbamate| G[Supportive care only] F --> H[Monitor respiratory function] G --> H H --> I{Respiratory paralysis} I -->|Yes| J[Mechanical ventilation] I -->|No| K[Continue supportive care] ``` ## Related Articles - [Veterinary Pharmacology Calculations for the NAVLE](/knowledge/veterinary-medicine/navle-exam-prep/veterinary-pharmacology-calculations-navle) - [Protease Inhibitors in Protein Extraction](/knowledge/molecular-biology/protease-inhibitors-in-protein-extraction-preventing-degradation-and-preserving-protein-integrity) - [Veterinary Pharmacology Drug Classes: A NAVLE Review](/knowledge/veterinary-medicine/navle-exam-prep/veterinary-pharmacology-drug-classes-a-navle-review) - [Veterinary Pharmacology Question Bank: How to Use It for NAVLE](/knowledge/veterinary-medicine/navle-exam-prep/veterinary-pharmacology-question-bank-how-to-use-it-for-navle) - [Designing Dose-Response Studies in Veterinary Pharmacology](/knowledge/veterinary-medicine/veterinary-research-methods/designing-dose-response-studies-veterinary-pharmacology) - [Veterinary Pharmacology and Therapeutics: Core Concepts for Clinicians](/knowledge/veterinary-medicine/clinical-pharmacology/veterinary-pharmacology-therapeutics-core-concepts-clinicians) - [Diphenoxylate-Atropine: Pharmacology and Vet Use](/knowledge/veterinary-medicine/clinical-pharmacology/diphenoxylate-atropine-pharmacology-and-vet-use) - [Potassium-Sparing Diuretics: Vet Pharmacology](/knowledge/veterinary-medicine/clinical-pharmacology/potassium-sparing-diuretics-vet-pharmacology) - [Acidic Drugs: Absorption and Pharmacology Basics](/knowledge/veterinary-medicine/clinical-pharmacology/acidic-drugs-absorption-and-pharmacology-basics) ## Sources 1. [Structural and Biological Evidence for Acetylcholinesterase-Targeted Insecticidal Activity in Musca domestica: A 4.5  Å Distance Correlation From Novel Benzenesulfonamide Derivatives.](https://pubmed.ncbi.nlm.nih.gov/42740432/) 2. [Osajin attenuates diazinon-induced pulmonary toxicity in rats.](https://pubmed.ncbi.nlm.nih.gov/42341431/) 3. [Dichlorvos toxicity on hemato-biochemical, histopathological, and behavioral parameters in the grass carp (Ctenopharyngodon idella).](https://pubmed.ncbi.nlm.nih.gov/41848943/) 4. [Temperature and relative humidity differentially affect deltamethrin and malathion toxicity in the mosquito Culex quinquefasciatus.](https://pubmed.ncbi.nlm.nih.gov/42602908/) 5. [Methomyl poisoning in dogs: report of 5 cases and literature review.](https://pubmed.ncbi.nlm.nih.gov/42725627/) 6. [In vitro and in silico inhibition of acetylcholinesterase by acetone extracts of Anvillea garcinii subsp. radiata (Coss. & Durieu) Anderb., Marrubium deserti (de Noé) Coss., and Asphodelus tenuifolius Cav. from the Algerian desert.](https://pubmed.ncbi.nlm.nih.gov/41761842/) 7. [Clinical manifestations, laboratory findings, treatment and outcome of acute organophosphate or carbamate intoxication in 39 cats.](https://pubmed.ncbi.nlm.nih.gov/35437770/) 8. [Suspected organophosphate delayed neurotoxicity in sheep associated with widespread lobed needlegrass (Nassella charruana)-induced skin perforations.](https://pubmed.ncbi.nlm.nih.gov/41940786/) 9. [Drosophila as a model in organophosphate toxicology.](https://pubmed.ncbi.nlm.nih.gov/42363862/) 10. [Plasma cholinesterase activity: A benchmark for rapid detection of pesticide poisoning in an avian scavenger.](https://pubmed.ncbi.nlm.nih.gov/36934922/) 11. [Antidotal Effects of the Antihistamine Diphenhydramine Against Cholinesterase Inhibitor Poisoning: A Meta-Analysis of Median Lethal Doses in Experimental Animals.](https://pubmed.ncbi.nlm.nih.gov/38505441/) 12. [Intermittent organophosphate pesticide exposure induces hepatic injury in goats with subclinical fatty liver via immune activation and energy metabolism reprogramming.](https://pubmed.ncbi.nlm.nih.gov/42648532/)